Merck Q1 Revenue Beats Estimates Despite Net Loss from Acquisition Charge
Merck reported $16.29 billion in quarterly revenue for Q1 2026, exceeding Wall Street expectations, though a large acquisition charge pushed the company to a net loss. Keytruda sales surged 12%, driving the beat.
Key facts
- Merck posted $16.29 billion in quarterly revenue.
- Revenue topped Wall Street forecasts.
- A big acquisition charge resulted in a net loss.
- Keytruda sales surged 12% in Q1 2026.
Entities
Institutions
- Merck
Sources
- Quartz —